FDA Inspection
US Specialty Formulations LLCUS Specialty Formulations LLC – FDA Inspection, Jan 14, 2026
Record Details
This FDA Inspection record concerns US Specialty Formulations LLC, with an inspection on January 14, 2026, issued by the Philadelphia District Office, covering human drugs.
View Company Profile
ID · e72c419c-3eb9-4794-a8df-38ab824d37c6
Inspection Facts
- Inspection number
- 1298396
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.84(d)(3)Certificates of Testing (Containers, Closures)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of US Specialty Formulations LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 26, 2025 | VAI | Philadelphia District Office | Drug Quality Assurance |
| July 2, 2024 | OAI | Drug Quality Assurance | |
| April 26, 2022 | OAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| July 23, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 29, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for US Specialty Formulations LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.